Sunday 1 August 2021
Home      All news      Contact us      RSS     
healtheuropa - 2 month ago

Study demonstrates long-lasting efficacy of COVID-19 vaccine programme

Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks. Biotechnology company Defence Therapeutics Inc specialises in the development of ADCs and therapeutics for cancer and infectious diseases. The organisation has recently announced its first lead candidate in its COVID-19 vaccine programme, AccuVAC-PT001. Defence’s ACCUMTM [ ] The post Study demonstrates long-lasting efficacy of COVID-19 vaccine programme appeared first on Health Europa.


Latest News
Hashtags:   

Study

 | 

demonstrates

 | 

lasting

 | 

efficacy

 | 

COVID

 | 

vaccine

 | 

programme

 | 

Sources